We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
-5.23%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$31.1B
AUM Growth
+$8.47B
(+37%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
35.15%
Top 10 Holdings %
Top 10 Hldgs %
26.71%
Holding
1,155
New
13
Increased
800
Reduced
137
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$917M |
| 2 |
Visa
V
|
+$671M |
| 3 |
Philip Morris
PM
|
+$570M |
| 4 |
Danaher
DHR
|
+$543M |
| 5 |
Accenture
ACN
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$70.5M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$11M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$7.66M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.55M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$5.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.53% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 12.43% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Consumer Staples | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGMO
976
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $302K | ﹤0.01% |
61,704
-1,170
| -2% | -$6.01K |
|
977
Intellia Therapeutics
NTLA
$1.68B
| $296K | ﹤0.01% |
5,282
+286
| +6% | +$17.7K |
|
978
Ryanair
RYAAY
$30.8B
| $296K | ﹤0.01% |
12,683
| – | – |
|
979
American Superconductor
AMSC
$1.56B
| $295K | ﹤0.01% |
67,326
-16,372
| -20% | -$84.7K |
|
980
Accuray
ARAY
$34.6M
| $294K | ﹤0.01% |
141,337
+1,777
| +1% | +$4.04K |
|
|
FPI
981
Farmland Partners
FPI
$425M
| $294K | ﹤0.01% |
23,226
+10,221
| +79% | +$146K |
|
982
CRISPR Therapeutics
CRSP
$5.23B
| $292K | ﹤0.01% |
4,464
+88
| +2% | +$6.38K |
|
|
RPT
983
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $291K | ﹤0.01% |
38,454
| – | – |
|
|
PLYM
984
DELISTED
Plymouth Industrial REIT
PLYM
| $288K | ﹤0.01% |
17,112
-2,400
| -12% | -$46.5K |
|
985
Xencor
XNCR
$1.64B
| $285K | ﹤0.01% |
10,977
+585
| +6% | +$16.8K |
|
986
Editas Medicine
EDIT
$453M
| $282K | ﹤0.01% |
23,027
+367
| +2% | +$5.72K |
|
|
CBL
987
CBL Properties
CBL
$1.76B
| $278K | ﹤0.01% |
10,839
| – | – |
|
|
GTLS
988
DELISTED
Chart Industries
GTLS
| $275K | ﹤0.01% |
1,494
-260
| -15% | -$48.2K |
|
|
LAND
989
Gladstone Land Corp
LAND
$354M
| $275K | ﹤0.01% |
15,174
+2,400
| +19% | +$56.2K |
|
990
HUTCHMED
HCM
$2.17B
| $271K | ﹤0.01% |
30,584
| – | – |
|
991
Gilat Satellite Networks
GILT
$864M
| $270K | ﹤0.01% |
50,651
-1,480
| -3% | -$9.43K |
|
|
UHT
992
Universal Health Realty Income Trust
UHT
$566M
| $266K | ﹤0.01% |
6,156
+1,000
| +19% | +$51.1K |
|
993
CONMED
CNMD
$1.48B
| $262K | ﹤0.01% |
3,273
+185
| +6% | +$17.5K |
|
|
RMO
994
DELISTED
Romeo Power, Inc.
RMO
| $260K | ﹤0.01% |
651,104
+50,528
| +8% | +$30.4K |
|
995
Blue Bird Corp
BLBD
$2.1B
| $258K | ﹤0.01% |
30,878
| – | – |
|
996
IDEAYA Biosciences
IDYA
$3.55B
| $258K | ﹤0.01% |
17,270
| – | – |
|
|
XRN
997
Chiron Real Estate Inc
XRN
$465M
| $256K | ﹤0.01% |
6,000
+920
| +18% | +$50.7K |
|
998
Microvast
MVST
$332M
| $251K | ﹤0.01% |
138,616
| – | – |
|
|
ZEV
999
DELISTED
Lightning eMotors, Inc.
ZEV
| $249K | ﹤0.01% |
8,024
+467
| +6% | +$26.6K |
|
1000
Fate Therapeutics
FATE
$319M
| $248K | ﹤0.01% |
11,052
-19
| -0.2% | -$549 |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Mitsubishi UFJ Asset Management held 1,155 positions worth $31.1B, up 37% from $22.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mitsubishi UFJ Asset Management deployed $10.9B of net new capital in Q3 2022, opening 13 new positions and adding to 800 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 34,960 shares worth $9.72M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares MBS ETF, an estimated $70.5M trimmed.
- Mitsubishi UFJ Asset Management's largest Q3 2022 buy was Shockwave Medical, Inc. Common Stock: 34,960 shares worth $9.72M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q3 2022, an estimated $917M increase.
- Mitsubishi UFJ Asset Management's biggest Q3 2022 reduction was iShares MBS ETF, cutting an estimated $70.5M.
- Mitsubishi UFJ Asset Management fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $4M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 27% of its $31.1B portfolio in Q3 2022.
- Mitsubishi UFJ Asset Management opened 13 new positions and closed 24 in Q3 2022.
- Mitsubishi UFJ Asset Management's portfolio value rose 37% quarter-over-quarter to $31.1B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.